Compound Profile

Uc II Collagen

Uc Ii Collagen carries a Grade B rating — moderate evidence.

Use extra caution Review medications, pregnancy status, chronic conditions, and clinician guidance before use. Details

Last reviewed: 2 sources citedReport a correctionProfile-wide ·B Moderate
Uc II Collagen monograph visual
Generated profile category visual

At a glance

From this profile's structured data
Evidence
Grade B
Safety
Safety evidence: one 180-day trial of a specific undenatured type II collagen product.
Profile context
Inflammation, Immune Function
Next steps

Continue reading

Quick stats

Evidence level
Moderate evidence
Typical onset
Varies by prep
Safety rating
Use extra caution: Interaction risk
Best for
Inflammation, Immune Function

Safety

Safety & Cautions

High caution

Caution level: High. Multiple caution categories apply, or the record uses avoid/contraindication language.

  • Interaction-AwareMedication or interaction context is explicitly noted.
  • Pregnancy/Breastfeeding CautionPregnancy or breastfeeding caution language is present.
Safety evidence
one 180-day trial of a specific undenatured type II collagen product
Who should avoid this?
No specific evidence-backed contraindication is documented for this profile. This is not the same as established safety.
Talk to a professional if
you use relevant medications, you are pregnant or breastfeeding.

Safety outcomes did not differ from placebo or glucosamine-chondroitin, but product-source allergy, pregnancy, breastfeeding, autoimmune disease, longer-term use, organ impairment, and medication-interaction safety remain insufficient.

Evidence Summary

Profile-wide ·B Moderate

Evidence lens

Useful signal, but study design, dose, and population still matter.

ModerateModerate evidence

Human clinical evidence: Not the primary signal

Mechanistic / preclinical: Mechanism mappedImmune Signaling Modulation · Oral Tolerance Induction · Th2/Treg Skewing (Proposed)

Research maturity: Theoretical / mechanistic researchMechanistic or unresolved evidence is kept separate from established human outcomes.

Safety boundary: Safety note availableReview medications, pregnancy status, chronic conditions, and clinician guidance before use.

This profile cites 2 human studies.

Evidence Strength

Confidence estimate based on the design quality and consistency of published clinical trials.

Moderate evidence

Uc II Collagen has a moderate evidence rating.

Inflammation SupportLongevity
Citation density
1.0
Sources
2
Effects
2
Research recency
Mixed recency
Evidence Grade

Grade B: Moderate Evidence

Evaluation of methodological rigor, population reach, and evidence alignment.

Design Match
Randomized controlled trial
Risk of Bias
Low
Consistency
Not assessed
Strongest recorded design is a randomized controlled trial, drawn from 2 recorded studies, 2 in people.
How evidence grades work

Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.

Strong
Multiple RCTs, consistent direction, adequate effect size
Moderate
Some RCTs or consistent observational data in humans
Preliminary / Mixed
Animal or in-vitro only, or conflicting human data
Traditional / Theoretical
Traditional use only; no controlled human trials
Clinical Study Summaries (2)0 human evidence sources · 0 human trials · Participant totals not consistently reported · Consistency not yet classifiable

What the evidence actually shows

This table contains 2 structured sources, including 0 human evidence sources; 0 are human trials. A reliable participant total cannot be calculated because sample size is not consistently structured in the cited sources. Source-to-conclusion relationships are not classified in this structured set, so consistency is not yet classifiable.

Profile-wide evidence grade: see the profile grade above · Confidence: not separately assigned

What would change our conclusion?

Larger, well-controlled human trials using comparable populations, doses, preparations, and clinically meaningful outcomes could materially strengthen or weaken this conclusion. Replication in a different population or a high-quality synthesis resolving current disagreement could also materially change confidence.

StudyDesignNDoseDurationPopulationOutcomeResult & magnitudeSource

Effects of Native Type II Collagen Treatment on Knee Osteoarthritis: A Randomized Controlled Trial

PubMed · Eurasian J Med · 2016

Background
Other / unclear

The study design is not yet classified clearly enough to infer its place in the evidence hierarchy.

PubMed

Undenatured type II collagen (UC-II®) for joint support: a randomized, double-blind, placebo-controlled study in healthy volunteers

PubMed · J Int Soc Sports Nutr · 2013

Background
Other / unclear

The study design is not yet classified clearly enough to infer its place in the evidence hierarchy.

PubMed

How Uc II Collagen Works

Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.

Mechanism Pathway — How Uc II Collagen Works

How Uc II Collagen WorksUc II Collagen acts on biological target pathways via anti inflammatory, leading to inflammation.Uc II CollagenBiological TargetBiological pathwayAnti Inflammatory↓ InflammationSystemic reliefImmune ModulationParallel pathway
CompoundTarget / ReceptorMechanismEffect / Outcome

Dosing

No standardized dose
No standardized dose is established for this ingredient in our source data. Preparations differ widely, so follow the standardization on the product you actually have and speak to a clinician before starting.
Mechanisms & biological pathways

Preclinical mechanism details from scientific profiles; these represent plausible pathways but do not guarantee clinical efficacy in humans.

  • Immune Signaling Modulation
  • Oral Tolerance Induction
  • Th2/Treg Skewing (Proposed)
  • Anti Inflammatory Cytokine Modulation
  • Inflammatory Signaling Modulation

Guides that use Uc II Collagen

Continue exploring

Related research paths

Compare & Sourcing

Compare side-by-side tradeoffs or verify active marker guidelines.

Free safety checklist

Get the Uc II Collagen evidence notes

Occasional research updates, safety context, and product-quality checks for supplement decisions.

We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.

Safety first · Harm reduction

This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.

Learn how we evaluate confidence, safety, and intensity on the methodology page.

Editorial Review

Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.

Editorial Standards →

Help improve this profile

Was this useful for your research?

These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.

Was this evidence summary clear?

Did you find what you were researching?

Compound profile context

How to interpret Uc II Collagen

Uc II Collagen compound profile with evidence context, key research topics, source notes, safety context, and references presented in an evidence-first… Use this compound profile to understand mechanism, evidence quality, and practical safety context before comparing products or building a stack. A biochemical pathway connection can be useful for discovery, but it is not the same as proven benefit in humans.

When reviewing Uc II Collagen, separate the active molecule from the product category around it. Dose form, absorption, extract standardization, medication interactions, and individual sensitivity can change the real-world risk-benefit picture.

For supplement planning, avoid combining multiple compounds with overlapping sedating, stimulating, serotonergic, blood-pressure, anticoagulant, or liver-metabolism effects unless a qualified clinician has reviewed the context.